Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
FOXO TECHNOLOGIES INC. issued 8,000 shares of the Company’s Series E Cumulative Redeemable Secured Preferred Stock of preferred stock to Rennova Health, Inc. for full satisfaction and extinguishment of $200,000 in aggregate previously advanced amounts.
- Security
- preferred stock
- Shares
- 8,000 shares of the Company’s Series E Cumulative Redeemable Secured Preferred Stock
- Purchaser
- Rennova Health, Inc.
- Consideration
- full satisfaction and extinguishment of $200,000 in aggregate previously advanced amounts
Exact text from the filing
”) effective December 31, 2025 with Rennova Health, Inc., a Delaware corporation (“ Rennova ”). Pursuant to the Exchange Agreement, in full satisfaction and extinguishment of $200,000 in aggregate previously advanced amounts (the “ Prior Advances ”) made by Rennova to the Company during the period from December 4, 2025 to December 10, 2025, the Company agreed
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
FOXO TECHNOLOGIES INC. entered into Series E Preferred Stock Exchange Agreement with Rennova Health, Inc. valued at $200,000 (effective 2025-12-31).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- Rennova Health, Inc.
- Value
- $200,000
- Effective
- 2025-12-31
Exact text from the filing
On February 6, 2026, FOXO Technologies Inc., a Delaware corporation (the “ Company ”), entered into a Series E Preferred Stock Exchange Agreement (the “ Exchange Agreement ”) effective December 31, 2025 with Rennova Health, Inc., a Delaware corporation (“ Rennova ”). Pursuant to the Exchange Agreement, in full satisfaction and extinguishment of $200,000 in aggregate previously advanced amounts (the “ Prior Advances ”) made by Rennova to the Company
View on SEC.gov